Beijing, China

Jingcai Chen


Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Jingcai Chen

Introduction

Jingcai Chen is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedical research, particularly in the development of therapeutic peptides. His work focuses on addressing critical health issues related to lung and gastrointestinal diseases.

Latest Patents

Jingcai Chen holds a patent for the invention titled "Prokineticin 2β peptide and its use." This patent describes a PK2β peptide, which acts as an agonist of prokineticin receptor 1. The peptide is useful for treating lung and gastrointestinal diseases or disorders mediated by PKR1 activity. This innovation highlights his commitment to advancing medical treatments.

Career Highlights

Jingcai Chen is currently employed at Janssen Pharmaceutica NV, a leading pharmaceutical company known for its innovative healthcare solutions. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

One of his notable coworkers is Changlu Liu, with whom he collaborates on various research projects. Their combined expertise enhances the potential for developing effective treatments in their area of focus.

Conclusion

Jingcai Chen's work exemplifies the impact of innovative thinking in the medical field. His contributions, particularly through his patent on the PK2β peptide, demonstrate his dedication to improving health outcomes. His career at Janssen Pharmaceutica NV further solidifies his role as a key player in biomedical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…